15 patents
Utility
Subtyping prostate cancer to predict response to hormone therapy
16 Jan 24
The present invention relates to methods, systems and kits for the diagnosis, prognosis and the determination of progression of cancer in a subject.
Elai Davicioni, Nicholas Erho, Shuang G. Zhao, S. Laura Chang, Felix Y. Feng
Filed: 9 Mar 18
Utility
Methods and Genomic Classifiers for Identifying Homologous Recombination Deficiency Prostate Cancer
4 Jan 24
The disclosure relates to methods, systems, kits and probe sets for the identification, determination, diagnosis, and/or prognosis of homologous recombination deficiency prostate cancer in a subject.
Edward Matthew Schaeffer, Elai Davicioni, Yang Liu, Adam Benjamin Weiner
Filed: 18 Nov 21
Utility
Genomic Classifiers for Prognosing and Treating Clinically Aggressive Luminal Bladder Cancer
13 Apr 23
The present disclosure pertains to the field of personalized medicine and methods for prognosing and treating bladder cancer.
Joep Jacobus de Jong, Yang Liu, Ewan A. Gibb, Elai Davicioni
Filed: 31 Mar 21
Utility
Cancer Diagnostics Using Biomarkers
3 Nov 22
Disclosed herein, in certain instances, are methods, systems and kits for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject.
Christine Buerki, Anamaria Crisan, Elai Davicioni, Nicholas George Erho, Mercedeh Ghadessi, Robert B. Jenkins, Ismael A. Vergara Correa
Filed: 11 Jun 21
Utility
Molecular Subtyping, Prognosis, and Treatment of Bladder Cancer
13 Oct 22
The present invention relates to methods, systems and kits for the diagnosis, prognosis, and treatment of bladder cancer in a subject.
Elai Davicioni, Hussam Al-Deen Ashab, Nicholas Erho, Peter Black
Filed: 23 Dec 21
Utility
Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
16 Aug 22
Methods, compositions, and kits for identifying individuals who will be responsive to post-operative radiation therapy for treatment of prostate cancer are disclosed.
Elai Davicioni, Hussam Al-Deen Ashab, Nicholas Erho, Shuang G. Zhao, Sei-Won Laura Chang, Felix Y. Feng
Filed: 24 Aug 17
Utility
Genetic Signatures to Predict Prostate Cancer Metastasis and Identify Tumor Aggressiveness
9 Jun 22
The present invention relates to methods, systems and kits for the diagnosis, prognosis and the determination of cancer progression of prostate cancer in a subject.
Elai Davicioni, Nicholas Erho, Hussam Al-Deen Ashab, Mohammed Alshalalfa
Filed: 30 Jul 21
Utility
Transcriptomic Profiling for Prognosis of Breast Cancer to Identify Subjects Who May Be Spared Adjuvant Systemic Therapy
3 Feb 22
Methods, systems, and kits for the diagnosis, prognosis, and treatment of breast cancer in a subject are disclosed.
S. Laura Chang, Elai Davicioni, Felix Feng
Filed: 6 Dec 19
Utility
Molecular subtyping, prognosis, and treatment of bladder cancer
28 Dec 21
The present invention relates to methods, systems and kits for the diagnosis, prognosis, and treatment of bladder cancer in a subject.
Elai Davicioni, Hussam Al-Deen Ashab, Nicholas Erho, Peter Black
Filed: 19 Jan 18
Utility
Use of Immune Cell-specific Gene Expression for Prognosis of Prostate Cancer and Prediction of Responsiveness to Radiation Therapy
14 Oct 21
Methods, systems, and kits for the diagnosis, prognosis and the determination of cancer progression of prostate cancer in a subject are disclosed.
Elai DAVICIONI, Nicholas George ERHO, Jonathan LEHRER, Felix Y. FENG, Shuang G. ZHAO
Filed: 2 Aug 18
Utility
Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness
3 Aug 21
The present invention relates to methods, systems and kits for the diagnosis, prognosis and the determination of cancer progression of prostate cancer in a subject.
Elai Davicioni, Nicholas Erho, Hussam Al-Deen Ashab, Mohammed Alshalalfa
Filed: 11 May 18
Utility
Cancer diagnostics using biomarkers
15 Jun 21
Disclosed herein, in certain instances, are methods, systems and kits for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject.
Christine Buerki, Anamaria Crisan, Elai Davicioni, Nicholas George Erho, Mercedeh Ghadessi, Robert B. Jenkins, Ismael A. Vergara Correa
Filed: 16 Aug 13
Utility
Subtyping Prostate Cancer to Predict Response to Hormone Therapy
6 May 21
The present invention relates to methods, systems and kits for the diagnosis, prognosis and the determination of progression of cancer in a subject.
Elai DAVICIONI, Nicholas ERHO, Shuang G. ZHAO, S. Laura CHANG, Felix Y. FENG
Filed: 9 Mar 18
Utility
Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
14 Dec 20
A system for expression-based discrimination of distinct clinical disease states in prostate cancer is provided that is based on the identification of sets of gene transcripts, which are characterized in that changes in expression of each gene transcript within a set of gene transcripts can be correlated with recurrent or non-recurrent prostate cancer.
Elai Davicioni
Filed: 5 Apr 16
Utility
Cancer diagnostics using non-coding transcripts
23 Dec 19
Disclosed herein, in certain instances, are methods for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject.
Elai Davicioni, Nicholas George Erho, Ismael A. Vergara Correa
Filed: 12 Dec 12
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first